Survival and pleurodesis outcome in patients with malignant pleural effusion - a systematic review.

IF 2.4 Q4 ONCOLOGY Pleura and Peritoneum Pub Date : 2021-02-08 eCollection Date: 2021-03-01 DOI:10.1515/pp-2020-0147
Maged Hassan, Elinor Harriss, Rachel M Mercer, Najib M Rahman
{"title":"Survival and pleurodesis outcome in patients with malignant pleural effusion - a systematic review.","authors":"Maged Hassan, Elinor Harriss, Rachel M Mercer, Najib M Rahman","doi":"10.1515/pp-2020-0147","DOIUrl":null,"url":null,"abstract":"<p><p>Malignant pleural effusion (MPE) is a common condition that presents with progressive breathlessness. Long term solutions are often required due to recurrence of effusion after simple drainage. Pleurodesis is one of the main options resorted to for long term control of MPE. There is data to suggest there may be a survival benefit for patients with MPE who achieve successful pleurodesis. A systematic review was carried out to explore this correlation and results suggest that there could be a survival difference according to pleurodesis outcome in patients with MPE. Fifteen studies (reported in 13 papers) were included; 13 (86.6%) of the studies showed survival difference in favour of pleurodesis success. The median [interquartile range] difference in survival between the two groups among the different studies was five [3.5-5.8] months. Most of the included studies suffered moderate to severe risk of bias and, thus, large prospective studies of patients undergoing pleurodesis are required to ascertain this effect.</p>","PeriodicalId":20231,"journal":{"name":"Pleura and Peritoneum","volume":"6 1","pages":"1-5"},"PeriodicalIF":2.4000,"publicationDate":"2021-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223802/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pleura and Peritoneum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/pp-2020-0147","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/3/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Malignant pleural effusion (MPE) is a common condition that presents with progressive breathlessness. Long term solutions are often required due to recurrence of effusion after simple drainage. Pleurodesis is one of the main options resorted to for long term control of MPE. There is data to suggest there may be a survival benefit for patients with MPE who achieve successful pleurodesis. A systematic review was carried out to explore this correlation and results suggest that there could be a survival difference according to pleurodesis outcome in patients with MPE. Fifteen studies (reported in 13 papers) were included; 13 (86.6%) of the studies showed survival difference in favour of pleurodesis success. The median [interquartile range] difference in survival between the two groups among the different studies was five [3.5-5.8] months. Most of the included studies suffered moderate to severe risk of bias and, thus, large prospective studies of patients undergoing pleurodesis are required to ascertain this effect.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
恶性胸腔积液患者的生存和胸膜切除术结果——一项系统综述。
恶性胸腔积液(MPE)是一种常见病,表现为进行性呼吸困难。单纯引流后积液复发,需要长期治疗。胸膜固定术是长期控制MPE的主要选择之一。有数据表明,MPE患者成功进行胸膜融合术可能会提高生存率。我们进行了一项系统综述来探讨这种相关性,结果表明MPE患者的胸膜切除术结局可能存在生存差异。纳入了15项研究(13篇论文报道);13例(86.6%)的研究显示生存差异有利于胸膜融合术的成功。在不同的研究中,两组之间的生存期中位数[四分位数范围]差异为5个月[3.5-5.8]个月。大多数纳入的研究存在中度至重度偏倚风险,因此需要对胸膜切除术患者进行大型前瞻性研究来确定这种影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.50
自引率
11.10%
发文量
23
审稿时长
9 weeks
期刊最新文献
Adhesion obstacles effect on PIPAC patients with primary unresectable or recurrent platinum-resistant peritoneal metastasis from ovarian cancer. Advancements in nebulizers for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Co-occurrence of peritoneal mesothelioma and genitourinary cancers: a case series with comparative outcomes. The addition of collagenase to BromAc ® for the management of inoperable pseudomyxoma peritonei - in vitro results. Comparison of clinical characteristics and outcomes between patients with complicated pleural infection caused by Streptococcus anginosus group and Klebsiella pneumoniae.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1